Transdifferentiated Human Vascular Smooth Muscle Cells are a New Potential Cell Source for Endothelial Regeneration

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Hong, Xuechong ^a   Margariti, Andriana ^b   Le Bras, Alexandra ^a   Jacquet, Laureen ^a   Kong, Wei ^c   Hu, Yanhua ^a   Xu, Qingbo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL CULTURE; CELL TRANSDIFFERENTIATION; COCULTURE; CYTOLOGY; HINDLIMB; HUMAN; ISCHEMIA; METABOLISM; MOUSE; REGENERATION; SCID MOUSE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HINDLIMB; HUMANS; ISCHEMIA; MICE; MICE, SCID; MUSCLE, SMOOTH, VASCULAR; REGENERATION; SIGNAL TRANSDUCTION;

EID: 85025135872     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-05665-7     Document Type: Article

References (54)

1. Deanfield, J. E., Halcox, J. P., Rabelink, T. J. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 115, 1285-1295, doi: 10.1161/CIRCULATIONAHA.106.652859 (2007).
2. Raval, Z., Losordo, D. W. Cell therapy of peripheral arterial disease: From experimental findings to clinical trials. Circulation research 112, 1288-1302, doi: 10.1161/CIRCRESAHA.113.300565 (2013).
3. Hong, X., Le Bras, A., Margariti, A., & Xu, Q. Reprogramming towards endothelial cells for vascular regeneration. GENES & DISEASES (2016).
4. Gomez, D., Owens, G. K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovascular research 95, 156-164, doi: 10.1093/cvr/cvs115 (2012).
5. Shankman, L. S. et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nature medicine 21, 628-637, doi: 10.1038/nm.3866 (2015).
6. Cherepanova, O. A. et al. Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective. Nature medicine 22, 657-665, doi: 10.1038/nm.4109 (2016).
7. Majesky, M. W. Developmental basis of vascular smooth muscle diversity. Arteriosclerosis, thrombosis, and vascular biology 27, 1248-1258, doi: 10.1161/ATVBAHA.107.141069 (2007).
8. Wang, G., Jacquet, L., Karamariti, E., Xu, Q. Origin and differentiation of vascular smooth muscle cells. The Journal of physiology 593, 3013-3030, doi: 10.1113/JP270033 (2015).
9. Ferreira, L. S. et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circulation research 101, 286-294, doi: 10.1161/CIRCRESAHA.107.150201 (2007).
10. Yamashita, J. et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96, doi: 10.1038/35040568 (2000).
11. Narazaki, G. et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498-506, doi: 10.1161/CIRCULATIONAHA.108.769562 (2008).
12. Margariti, A. et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proceedings of the National Academy of Sciences of the United States of America 109, 13793-13798, doi: 10.1073/pnas.1205526109 (2012).
13. Kurian, L. et al. Conversion of human fibroblasts to angioblast-like progenitor cells. Nature methods 10, 77-83, doi: 10.1038/nmeth.2255 (2013).
14. Morita, R. et al. ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 112, 160-165, doi: 10.1073/pnas.1413234112 (2015).
15. Li, J. et al. Conversion of human fibroblasts to functional endothelial cells by defined factors. Arteriosclerosis, thrombosis, and vascular biology 33, 1366-1375, doi: 10.1161/ATVBAHA.112.301167 (2013).
16. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386, doi: 10.1016/j.cell.2010.07.002 (2010).
17. Han, J. K. et al. Direct conversion of adult skin fibroblasts to endothelial cells by defined factors. Circulation 130, 1168-1178, doi: 10.1161/CIRCULATIONAHA.113.007727 (2014).
18. Ji, H. et al. Transdifferentiation of human endothelial progenitors into smooth muscle cells. Biomaterials 85, 180-194, doi: 10.1016/j.biomaterials.2016.01.066 (2016).
19. Cahan, P. et al. CellNet: Network biology applied to stem cell engineering. Cell 158, 903-915, doi: 10.1016/j.cell.2014.07.020 (2014).
20. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676, doi: 10.1016/j.cell.2006.07.024 (2006).
21. Xu, J., Du, Y., Deng, H. Direct lineage reprogramming: Strategies, mechanisms, and applications. Cell stem cell 16, 119-134, doi: 10.1016/j.stem.2015.01.013 (2015).
22. Efe, J. A. et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nature cell biology 13, 215-222, doi: 10.1038/ncb2164 (2011).
23. Karamariti, E. et al. Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circulation research 112, 1433-1443, doi: 10.1161/CIRCRESAHA.111.300415 (2013).
24. Owens, G. K., Kumar, M. S., Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiological reviews 84, 767-801, doi: 10.1152/physrev.00041.2003 (2004).
25. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872, doi: 10.1016/j.cell.2007.11.019 (2007).
26. Lee, T. H. et al. Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circulation research 106, 120-128, doi: 10.1161/CIRCRESAHA.109.207902 (2010).
27. Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997).
28. Mackie, A. R., Losordo, D. W. CD34-positive stem cells: In the treatment of heart and vascular disease in human beings. Texas Heart Institute journal/from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 38, 474-485 (2011).
29. Di Bernardini, E. et al. Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor beta2 (TGF-beta2) pathways. The Journal of biological chemistry 289, 3383-3393, doi: 10.1074/jbc.M113.495531 (2014).
30. Campagnolo, P. et al. c-Kit+ progenitors generate vascular cells for tissue-engineered grafts through modulation of the Wnt/Klf4 pathway. Biomaterials 60, 53-61, doi: 10.1016/j.biomaterials.2015.04.055 (2015).
31. Tsai, T. N. et al. Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model. The American journal of pathology 181, 362-373, doi: 10.1016/j.ajpath.2012.03.021 (2012).
32. Campagnolo, P. et al. Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/beta-Catenin Is Protective in Vessel Graft Models. PloS one 10, e0125122, doi: 10.1371/journal.pone.0125122 (2015).
33. Esteban, M. A. et al. The mesenchymal-to-epithelial transition in somatic cell reprogramming. Current opinion in genetics & development 22, 423-428, doi: 10.1016/j.gde.2012.09.004 (2012).
34. Li, R. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell stem cell 7, 51-63, doi: 10.1016/j.stem.2010.04.014 (2010).
35. Samavarchi-Tehrani, P. et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell stem cell 7, 64-77, doi: 10.1016/j.stem.2010.04.015 (2010).
36. Gridley, T. Notch signaling in vascular development and physiology. Development 134, 2709-2718, doi: 10.1242/dev.004184 (2007).
37. Benedito, R. et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124-1135, doi: 10.1016/j.cell.2009.03.025 (2009).
38. Patenaude, A. et al. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism. Cancer research 74, 2402-2411, doi: 10.1158/0008-5472.CAN-12-4038 (2014).
39. Fadini, G. P., Losordo, D., Dimmeler, S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circulation research 110, 624-637, doi: 10.1161/CIRCRESAHA.111.243386 (2012).
40. Szabo, E. et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521-526, doi: 10.1038/nature09591 (2010).
41. Buganim, Y. et al. Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors. Cell stem cell 11, 373-386, doi: 10.1016/j.stem.2012.07.019 (2012).
42. Muraoka, N. et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. The EMBO journal 33, 1565-1581, doi: 10.15252/embj.201387605 (2014).
43. Bray, S. J. Notch signalling: A simple pathway becomes complex. Nature reviews. Molecular cell biology 7, 678-689, doi: 10.1038/nrm2009 (2006).
44. Kageyama, R., Ohtsuka, T., Kobayashi, T. The Hes gene family: Repressors and oscillators that orchestrate embryogenesis. Development 134, 1243-1251, doi: 10.1242/dev.000786 (2007).
45. Xu, J. et al. Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. American journal of physiology. Cell physiology 296, C535-543, doi: 10.1152/ajpcell.00310.2008 (2009).
46. Schober, A. et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nature medicine 20, 368-376, doi: 10.1038/nm.3487 (2014).
47. Kwon, S. M. et al. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 118, 157-165, doi: 10.1161/CIRCULATIONAHA.107.754978 (2008).
48. Lee, J. B. et al. Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Blood 122, 1162-1173, doi: 10.1182/blood-2012-12-471649 (2013).
49. Annex, B. H. Therapeutic angiogenesis for critical limb ischaemia. Nature reviews. Cardiology 10, 387-396, doi: 10.1038/nrcardio.2013.70 (2013).
50. Wong, M. M., Hong, X., Karamariti, E., Hu, Y., Xu, Q. Generation and Grafting of Tissue-engineered Vessels in a Mouse Model. J. Vis. Exp., 10.3791/52565 (2015).
51. Bar-Nur, O. et al. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nature biotechnology 33, 761-768, doi: 10.1038/nbt.3247 (2015).
52. Itay Maza et al. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Nature Biotechnology 33(7), 769-774 (2015).
53. L. Zeng, Q. et al. Vascular Endothelial Cell Growth-Activated XBP1 Splicing in Endothelial Cells Is Crucial for Angiogenesis. Circulation 127(16), 1712-1722 (2013).
54. Russell M.L. et al. Hyaluronan Is Crucial for Stem Cell Differentiation into Smooth Muscle Lineage. STEM CELLS 34(5), 1225-1238 (2016).